4SC Announces Start of Dosing in First-in-Man Phase I Study with 4SC-203
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company, today announced the start of dosing i…
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company, today announced the start of dosing i…
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indic…
4SC AG (Frankfurt, Prime Standard: VSC) reports today on the financial result of the financial year 2007. Revenues durin…